Navigation Links
VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics
Date:6/24/2008

ST. JOSEPH, Mich., June 24 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that VTT has licensed MetaCore(TM). VTT develops novel high-throughput methods for cancer research, drug discovery and diagnostics. The focus is in investigating mechanisms of cancer development and progression, identification of therapeutic targets and exploration of the mechanism of action of anti-cancer compounds. VTT will utilize MetaCore and MetaDrug in high-throughput compound screening, RNA interference experiments, cell biology and bioinformatics projects to identify pathways and networks important in translational cancer research.

There are 85 researchers and staff members working in VTT's Medical Biotechnology Knowledge Centre in Turku. The research is funded by the European Commission and the Academy of Finland. VTT accommodates two EU Marie Curie Centre of Excellence teams and coordinates the Academy of Finland Centre of Excellence for translational genome-wide biology. Further information on VTT: http://www.vtt.fi.

"VTT was our first customer in Finland and an important internationally recognized cancer research center," said Julie Bryant, GeneGo's VP of Business development. "We have seen a growing need for analysis platforms focused in disease areas recently. We responded by developing disease pathway ontologies, biomarker and drug databases and new interactome analysis tools. We are pleased that our expertise in cancer is appreciated by professional molecular oncologists at VTT."

About GeneGo, Inc.

GeneGo, Inc. systems biology technology for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) wi
'/>"/>

SOURCE GeneGo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories
2. Mr. Richard Decker Appointed Technical Director of Edgewood Chemical Biological Center
3. Genencor Appoints New Executive Vice President - Technical Enzymes
4. Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments
5. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
6. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
7. Nuevolution Announces Research and Development Collaboration with Merck & Co. Inc.
8. Decision Resources, Inc. Acquires Manhattan Research
9. Partnering for Philanthropy Conference Launched to Unite Innovative Non-profit Research Organizations with Philanthropists and Industry
10. HIPAA Privacy Rule Impedes Biomedical Research
11. Stem Cell Researcher Wins Award for Excellence for Work With the ImageStream(R) System
Post Your Comments:
*Name:
*Comment:
*Email:
Other Biology Technology:Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company 2GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners 2Mindray Announces 2008 Fourth Quarter and Full Year Results 2Mindray Announces 2008 Fourth Quarter and Full Year Results 3Mindray Announces 2008 Fourth Quarter and Full Year Results 4Mindray Announces 2008 Fourth Quarter and Full Year Results 5Mindray Announces 2008 Fourth Quarter and Full Year Results 6Mindray Announces 2008 Fourth Quarter and Full Year Results 7Mindray Announces 2008 Fourth Quarter and Full Year Results 8Mindray Announces 2008 Fourth Quarter and Full Year Results 9Mindray Announces 2008 Fourth Quarter and Full Year Results 10Mindray Announces 2008 Fourth Quarter and Full Year Results 11Mindray Announces 2008 Fourth Quarter and Full Year Results 12Mindray Announces 2008 Fourth Quarter and Full Year Results 13Mindray Announces 2008 Fourth Quarter and Full Year Results 14Mindray Announces 2008 Fourth Quarter and Full Year Results 15Mindray Announces 2008 Fourth Quarter and Full Year Results 16Mindray Announces 2008 Fourth Quarter and Full Year Results 17Mindray Announces 2008 Fourth Quarter and Full Year Results 18Mindray Announces 2008 Fourth Quarter and Full Year Results 19